ORGANIC
LETTERS
2011
Vol. 13, No. 8
1984–1987
Palladium-Catalyzed C,N-Cross Coupling
Reactions of 3-Halo-2-aminopyridines
Felix Perez and Ana Minatti*
Department of Medicinal Chemistry, Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
Received February 8, 2011
ABSTRACT
A simple approach toward N3-substituted-2,3-diaminopyridines is presented, based on Pd-catalyzed C,N-cross coupling. The use of RuPhos- and
BrettPhos-precatalysts in combination with LiHMDS allows for C,N-cross coupling reactions of unprotected 3-halo-2-aminopyridines with primary
and secondary amines.
In the past decade, N3-subsituted 2,3-diaminopyridines
have been disclosed as potential therapeutics1À3 for multi-
ple indications. They also serve as versatile intermediates
in the synthesis of further elaborated, biologically active
heterocycles.4À8
on 3-halo-2-nitropyridines followed by nitro reduction,5,9
reductive alkylation4,8,10 of 2,3-diaminopyridines, or
amide coupling6,8 of the aforementioned diamine fol-
lowed by reduction.11 Additionally, two modestlyefficient
copper-catalyzed aminations have been described, which
are limited to 2-amino-3-iodopyridines7 or the corre-
sponding boronic ester.2 Most importantly, all methods
described to date are limited to the synthesis of N3-
alkylated 2,3-diaminopyridines while N3-arylated products
remain inaccessible.
Given the potential utility of N3-subsituted 2,3-diami-
nopyridines, we felt that there was a need for a general and
convenient synthetic method for their construction. We
envisioned that a Pd-catalyzed C,N-cross coupling reac-
tion of 3-bromo-2-aminopyridine might be amenable to
the problem, given the maturity of the field and several
recent advances.12
Despite the emerging utility of N3-substituted 2,3-
diaminopyridines, the known synthetic routes remain
mostly limited to two-step procedures: SNAr reactions
(1) Kanai, K.; Hashimoto, K.; Goto, K. JP Patent 62223173, 1987.
(2) Steinig, A. G.; Mulvihill, M. J.; Wang, J.; Werner, D. S.; Weng,
Q.; Kan, J.; Coate, H.; Chen, X. U.S. Patent 2009197862, 2009.
(3) (a) Illig, C. R.; Ballentine, S. K.; Chen, J.; Meegalia, S,; Rudolph,
J.; Wall, M. J.; Wilson, K. J.; Desjarlais, R.; Manthey, C. L.; Flores,
C. M.; Molloy, C. J. WO Patent 2006047504, 2006. (b) Illig, C. R.; Chen,
J.; Wall, M. J.; Wilson, K. J.; Ballentine, S. K.; Rudolph, M. J.; DesJarlais,
R. L.; Chen, Y.; Schubert, C.; Petrounia, I.; Crysler, C. S.; Molloy, C. J.;
Chaikin, M. A.; Manthey, C. L.; Player, M. R.; Tomczuk, B. E.; Meegalla,
S. K. Bioorg. Med. Chem. Lett. 2008, 18, 1642.
(4) Goehring, R. R.; Matsumura, A. A,; Shao, B.; Taoda, Y.; Tsuno,
N.; Whitehead, J. W. F.; Yao, J. WO Patent 2009027820, 2009.
(5) Jones, E. D.; Coates, J. A. V.; Rhodes, D. I.; Deadman, J. J.; Van-
Degraff, N. A.; Winfiled, L. J.; Thienthong, N.; Issa, W.; Choi, N.;
Macfarlane, K. WO Patent 2008077188, 2008.
The potential challenges of3-bromo-2-aminopyridine as
the substrate in a Pd-catalyzed C,N-cross coupling reac-
tion are 3-fold: (1) prevention or retardation of oxidative
(6) Grewal, G,; Hennessy, E,; Kamhi, V.; Li, D.; Lyne, P.; Oza, V.;
Saeh, J. C.; Su, Q.; Yang, B. WO Patent 2008056150, 2008.
(7) Shipps, G. W. Jr.; Cheng, C. C.; Huang, X.; Fischmann, T. O.;
Duca, J. S.; Richards, M.; Zeng, H.; Sun, B.; Reddy, P. A.; Wong, T. T.;
Tadikonda, P. K.; Siddiqui, M. A.; Labroli, M. M.; Poker, C.; Guzi, T. J.
WO Patent 2008054702, 2008.
(8) Ohtsuka, M.; Haginoya, N.; Ichikawa, M.; Matsunaga, H.; Saito,
H.; Shibata, Y.; Tsunemi, T.; Ishibashi, K. WO Patent 2010016490,
2010.
(10) Khanna, I. K.; Weier, R. M.; Lentz, K. T.; Swenton, L.; Lankin,
D. C. J. Org. Chem. 1995, 60, 960.
(11) Additionally, the synthesis of 3-butylamino-2-amino-pyridine
via nucleophilic substitution has been reported: Liu, Y.; Zhang, W.;
Sayre, L. M J. Heterocycl. Chem. 2010, 47, 683.
(12) (a) Buchwald, S. L.; Mauger, C.; Mignani, G.; Scholz, U. Adv.
Synth. Catal. 2006, 348, 23. (b) Tasler, S.; Mies, J.; Langa, M. Adv.
Synth. Catal. 2007, 349, 2286. (c) Torborg, C.; Beller, M. Adv. Synth.
Catal. 2009, 351, 3027. (d) Surry, D. S.; Buchwald, S. L. Chem. Sci. 2010,
2, 27.
(9) Exception: For an SNAr on 3-bromo-2-amino-5-phenylpyridine
under harsh reaction conditions, seeChrisman, W.; Knize, M. G.;
Tanga, M. J. J. Heterocyclic Chem. 2008, 45, 1641.
r
10.1021/ol200371n
Published on Web 03/25/2011
2011 American Chemical Society